Moderna’s Covid Booster Supply Hit by Manufacturing Issues (4)

Sept. 20, 2022, 9:40 PM UTC

Some pharmacies are reporting shortages of Moderna Inc.’s new bivalent booster shot for Covid-19 as one factory used in producing the vaccine remains offline following a safety inspection.

The US government supply of Moderna’s shot is currently limited, causing appointments for the product to vary across the country, a Walgreens Boots Alliance Inc. pharmacy spokesperson said in an emailed statement. Meanwhile, CVS Health Corp. says some of its drugstores have used all of the updated shots they received from the government, and the company is trying to get more doses.

Moderna has been coping without one of its vaccine-manufacturing ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.